» Articles » PMID: 31641325

Stress Reduction in the Prevention of Left Ventricular Hypertrophy: A Randomized Controlled Trial of Transcendental Meditation and Health Education in Hypertensive African Americans

Overview
Journal Ethn Dis
Date 2019 Oct 24
PMID 31641325
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background: African Americans have disproportionately high rates of cardiovascular disease (CVD). Left ventricular hypertrophy (LVH) is an independent risk factor for CVD and may contribute to this disparity. Psychological stress contributes to LVH in African Americans and other populations.

Objective: This study evaluated the effects of stress reduction with the Transcendental Meditation (TM) technique on preventing LVH in African American adults with hypertension.

Setting: Martin Luther King Hospital - Charles R. Drew University of Medicine and Science, Los Angeles, CA.

Method: In this trial, 85 African American adults (average 52.8 years) were randomly assigned to either TM program or health education (HE) control group and completed posttesting. Participants were tested at baseline and after six months for left ventricular mass index (LVMI) by M-mode echocardiography, blood pressure, psychosocial stress and behavioral factors. Change in outcomes was analyzed between groups by ANCOVA and within groups by paired t-test.

Results: The TM group had significantly lower LVMI compared with the HE group (-7.55gm/m, 95% CI -14.78 to -.34 gm/m, P=.040). Both interventions showed significant within group reductions in BP, (SBP/DBP changes for TM: -5/ -3 mm Hg, and for HE: -7/-6 mm Hg, P=.028 to <.001) although between group changes were not significant. In addition, both groups showed significant reductions in anger (P=.002 to .001). There were no other changes in lifestyle factors.

Conclusions: These findings indicate that stress reduction with TM was effective in preventing LVMI progression and thus may prevent LVH and associated CVD in high-risk African American patients.

Citing Articles

Mind-body therapy for cardiometabolic risk in U.S. middle-aged Black adults: a scoping review.

Martin D, Hook J, Kim S, Larkey L, Lee R Front Public Health. 2025; 13:1480369.

PMID: 40051519 PMC: 11883691. DOI: 10.3389/fpubh.2025.1480369.


Comprehensive Review of Chronic Stress Pathways and the Efficacy of Behavioral Stress Reduction Programs (BSRPs) in Managing Diseases.

Shchaslyvyi A, Antonenko S, Telegeev G Int J Environ Res Public Health. 2024; 21(8).

PMID: 39200687 PMC: 11353953. DOI: 10.3390/ijerph21081077.


Effect of Meditation, Mindfulness-Based Stress Reduction, and Relaxation Techniques as Mind-Body Medicine Practices to Reduce Blood Pressure in Cardiac Patients: A Systematic Review and Meta-Analysis.

Wankhar D, Kumar A, Vijayakumar V, A V, Balakrishnan A, Ravi P Cureus. 2024; 16(4):e58434.

PMID: 38765359 PMC: 11099499. DOI: 10.7759/cureus.58434.


Psychological interventions for depression and anxiety in patients with coronary heart disease, heart failure or atrial fibrillation.

Ski C, Taylor R, McGuigan K, Long L, Lambert J, Richards S Cochrane Database Syst Rev. 2024; 4:CD013508.

PMID: 38577875 PMC: 10996021. DOI: 10.1002/14651858.CD013508.pub3.


Meditation for the primary and secondary prevention of cardiovascular disease.

Rees K, Takeda A, Court R, Kudrna L, Hartley L, Ernst E Cochrane Database Syst Rev. 2024; 2:CD013358.

PMID: 38358047 PMC: 10867897. DOI: 10.1002/14651858.CD013358.pub2.


References
1.
Pocock S, McMurray J, Collier T . Statistical Controversies in Reporting of Clinical Trials: Part 2 of a 4-Part Series on Statistics for Clinical Trials. J Am Coll Cardiol. 2015; 66(23):2648-2662. DOI: 10.1016/j.jacc.2015.10.023. View

2.
Duraimani S, Schneider R, Randall O, Nidich S, Xu S, Ketete M . Effects of Lifestyle Modification on Telomerase Gene Expression in Hypertensive Patients: A Pilot Trial of Stress Reduction and Health Education Programs in African Americans. PLoS One. 2015; 10(11):e0142689. PMC: 4646647. DOI: 10.1371/journal.pone.0142689. View

3.
Grassi G . Sympathetic overdrive as an independent predictor of left ventricular hypertrophy: prospective evidence. J Hypertens. 2006; 24(5):815-7. DOI: 10.1097/01.hjh.0000222748.37078.2d. View

4.
Bauml M, Underwood D . Left ventricular hypertrophy: an overlooked cardiovascular risk factor. Cleve Clin J Med. 2010; 77(6):381-7. DOI: 10.3949/ccjm.77a.09158. View

5.
Paul-Labrador M, Polk D, Dwyer J, Velasquez I, Nidich S, Rainforth M . Effects of a randomized controlled trial of transcendental meditation on components of the metabolic syndrome in subjects with coronary heart disease. Arch Intern Med. 2006; 166(11):1218-24. DOI: 10.1001/archinte.166.11.1218. View